TNFα-producing CD4+ T cells dominate the SARS-CoV-2-specific T cell response in COVID-19 outpatients and are associated with durable antibodies
(Hinzugefügt: 10.05.2022 um 08:21 Uhr)
SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity
(Hinzugefügt: 16.03.2022 um 13:51 Uhr)
Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues
(Hinzugefügt: 11.03.2022 um 10:42 Uhr)
Cutting Edge: Serum but Not Mucosal Antibody Responses Are Associated with Pre-Existing SARS-CoV-2 Spike Cross-Reactive CD4+ T Cells following BNT162b2 Vaccination in the Elderly
(Hinzugefügt: 14.02.2022 um 16:30 Uhr)
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals
(Hinzugefügt: 10.01.2022 um 12:17 Uhr)
Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response
(Hinzugefügt: 30.12.2021 um 11:43 Uhr)
Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study
(Hinzugefügt: 18.12.2021 um 15:01 Uhr)
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
(Hinzugefügt: 13.12.2021 um 11:18 Uhr)
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques
(Hinzugefügt: 04.12.2021 um 18:55 Uhr)
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques
(Hinzugefügt: 04.12.2021 um 18:55 Uhr)
SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments
(Hinzugefügt: 20.11.2021 um 11:03 Uhr)
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
(Hinzugefügt: 19.11.2021 um 20:17 Uhr)
Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques
(Hinzugefügt: 24.08.2021 um 17:19 Uhr)
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
(Hinzugefügt: 03.07.2021 um 17:54 Uhr)
Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
(Hinzugefügt: 01.07.2021 um 08:47 Uhr)
Landscape of epitopes targeted by T cells in 852 convalescent COVID-19 patients: Meta-analysis, immunoprevalence and web platform
(Hinzugefügt: 27.05.2021 um 15:35 Uhr)
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
(Hinzugefügt: 26.05.2021 um 08:47 Uhr)
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease.
(Hinzugefügt: 20.05.2021 um 06:38 Uhr)
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients
(Hinzugefügt: 06.05.2021 um 09:24 Uhr)
Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination
(Hinzugefügt: 23.04.2021 um 12:19 Uhr)
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naïve precursor frequency and T cell receptor promiscuity
(Hinzugefügt: 18.04.2021 um 17:11 Uhr)
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients
(Hinzugefügt: 18.04.2021 um 07:47 Uhr)
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naïve precursor frequency and T cell receptor promiscuity
(Hinzugefügt: 17.04.2021 um 09:31 Uhr)
Single Prime hAd5 Spike (S) + Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean S- and N- T-Cell Responses Equivalent to T-Cell Responses from Patients Previously Infected with SARS-CoV-2
(Hinzugefügt: 08.04.2021 um 06:29 Uhr)
Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees
(Hinzugefügt: 01.04.2021 um 19:02 Uhr)
How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era
(Hinzugefügt: 29.03.2021 um 06:56 Uhr)
Monozygotic twins discordant for severe clinical recurrence of COVID-19 show drastically distinct T cell responses to SARS-Cov-2
(Hinzugefügt: 29.03.2021 um 06:37 Uhr)
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals
(Hinzugefügt: 25.03.2021 um 06:58 Uhr)
Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection
(Hinzugefügt: 12.03.2021 um 18:15 Uhr)